Ausgabe 5/2019
Inhalt (13 Artikel)
Molecular Testing and Diagnostics (J Khoury, Section Editor)
Circulating Tumor Cells: State-of-the-art Update on Technologies and Clinical Applications
Kristofor Yap, Evan N. Cohen, James M. Reuben, Joseph D. Khoury
Molecular Testing and Diagnostics (J Khoury, Section Editor)
Liquid Biopsy by Next-Generation Sequencing: a Multimodality Test for Management of Cancer
Hanadi El Achi, Joseph D. Khoury, Sanam Loghavi
Molecular Testing and Diagnostics (J Khoury, Section Editor)
Immunohistochemistry Innovations for Diagnosis and Tissue-Based Biomarker Detection
Narittee Sukswai, Joseph D. Khoury
Molecular Testing and Diagnostics (J Khoury, Section Editor)
Philadelphia-Negative Myeloproliferative Neoplasms: Laboratory Workup in the Era of Next-Generation Sequencing
Zhuang Zuo, Shaoying Li, Jie Xu, M. James You, Joseph D. Khoury, C. Cameron Yin
Molecular Testing and Diagnostics (J Khoury, Section Editor)
Acute Myeloid Leukemia: from Mutation Profiling to Treatment Decisions
Courtney DiNardo, Curtis Lachowiez
Molecular Testing and Diagnostics (J Khoury, Section Editor)
Molecular Mechanisms of Resistance to Tyrosine Kinase Inhibitors
Marjan Yaghmaie, Cecilia CS Yeung
B-cell NHL, T-cell NHL, and Hodgkin Lymphoma (J Amengual, Section Editor)
The Role of PI3K Inhibition in Lymphoid Malignancies
Gottfried von Keudell, Alison J. Moskowitz
B-cell NHL, T-cell NHL, and Hodgkin Lymphoma (J Amengual, Section Editor)
IMiDs New and Old
Samuel Yamshon, Jia Ruan
B-cell NHL, T-cell NHL, and Hodgkin Lymphoma (J Amengual, Section Editor)
Mechanisms of Resistance to Monoclonal Antibodies (mAbs) in Lymphoid Malignancies
Pallawi Torka, Mathew Barth, Robert Ferdman, Francisco J. Hernandez-Ilizaliturri
B-Cell NHL, T-Cell NHL, and Hodgkin Lymphoma (J Amengual, Section Editor)
Chromatin-Remodeled State in Lymphoma
Yuxuan Liu, Yulissa Gonzalez, Jennifer E. Amengual
CART and Immunotherapy (M Ruella and P Hanley, Section Editors)
Multi-Specific CAR Targeting to Prevent Antigen Escape
Zachary Walsh, Savannah Ross, Terry J. Fry
Myeloproliferative Neoplasms (B Stein, Section Editor)
Novel Therapies in Myeloproliferative Neoplasms (MPN): Beyond JAK Inhibitors
Minas P. Economides, Srdan Verstovsek, Naveen Pemmaraju
Chronic Lymphocytic Leukemias (N Jain, Section Editor)
Venetoclax for the Treatment of Chronic Lymphocytic Leukemia
Herbert Eradat